Insider · CIK 0001366244

Palleiko Benjamin L

Reports to the SEC for 4 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001366244

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	KalVista Pharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−480K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−47.4K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−29.6K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−33.8K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−71.7K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−52.6K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−33.8K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−75K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−85K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−37.5K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−20K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−25.8K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−40K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−114K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−125K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−256K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−92.6K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−305K sh	—	—	0
2026-05-22	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−10.9K sh	$26.78	−$293K	479,989
2026-05-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+23.3K sh	—	—	490,915
2026-05-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−23.3K sh	—	—	255,750
2026-05-18	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,129 sh	$26.76	−$30.2K	467,665
2026-05-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+2,419 sh	—	—	468,794
2026-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−2,419 sh	—	—	0
2026-05-12	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−3,322 sh	$26.71	−$88.7K	466,375
2026-05-11	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+7,120 sh	—	—	469,697
2026-05-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−7,120 sh	—	—	92,560
2026-04-17	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−9,550 sh	$20.22	−$193K	462,577
2026-04-16	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+20.3K sh	—	—	472,127
2026-04-16	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−20.3K sh	—	—	304,688
2026-03-09	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−6,693 sh	$16.08	−$108K	451,815
2026-03-06	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15.6K sh	—	—	458,508
2026-03-06	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15.6K sh	—	—	125,001
2026-02-23	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−10K sh	$15.57	−$156K	442,883
2026-02-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+23.3K sh	—	—	452,917
2026-02-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−23.3K sh	—	—	279,000
2026-02-18	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,038 sh	$15.00	−$15.6K	429,667
2026-02-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+2,419 sh	—	—	430,705
2026-02-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−2,419 sh	—	—	2,419
2026-02-12	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−3,354 sh	$15.70	−$52.7K	428,286
2026-02-11	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+7,120 sh	—	—	431,640
2026-02-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−7,120 sh	—	—	99,680
2026-01-16	KalVista Pharmaceuticals, Inc.Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+325K sh	—	—	325,000
2025-12-08	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−7,294 sh	$16.51	−$120K	424,520
2025-12-06	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15.6K sh	—	—	431,814
2025-12-06	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15.6K sh	—	—	140,626
2025-11-24	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−10.9K sh	$13.45	−$147K	416,189
2025-11-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+23.3K sh	—	—	427,129
2025-11-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−23.3K sh	—	—	302,250
2025-11-18	KalVista Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−4,466 sh	$14.48	−$64.7K	403,879

Recent filings

Accepted (ET)
Jun 114
Palleiko Benjamin L0001366244-26-000012
SEC(opens sec.gov)
May 264
Palleiko Benjamin L0001366244-26-000010
SEC(opens sec.gov)

Companies

Address

1001 PAGE MILL ROAD BUILDING 4, SUITE 200B

PALO ALTO, CA, 93404